AusperBio

AusperBio develops differentiated oligonucleotide therapeutics and targeted delivery technologies, with an initial focus on chronic hepatitis B.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series C
Initial Investment Year
2026
Ausper Bio Hover Image